FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249529992> ?p ?o ?g. }

• W4249529992 abstract "No AccessJournal of UrologyEducational article1 Mar 2006Erectile Dysfunction Arthur L. Burnett Arthur L. BurnettArthur L. Burnett Financial interest and/or other relationship with Pfizer, Guilford Pharmaceuticals, Bayer/GlaxoSmithKline and Lilly/ICOS. More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)00309-5AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: An overview of the latest concepts advanced with regard to the epidemiology, pathophysiology, and management of male ED is provided. Materials and Methods: Published literature and current paradigms promoted by consensus bodies in the field with regard to the management of ED were reviewed. Results: ED is a neurovascular phenomenon modulated by hormonal, local biochemical, and biomechanical/structural factors of the penis. Once viewed primarily as a psychological issue, ED is now understood to represent predominantly organic etiologies. It has a significant association with cardiovascular disease and could serve as a harbinger of subsequent cardiovascular events. Goal directed assessment and management implies a focus on patient (and partner) preferences regarding various treatment options. These options range from oral pharmacological agents to surgery and may be pursued according to a stepwise management approach. Psychosocial interventions also may serve as useful therapeutic adjuncts. Conclusions: ED is a highly manageable disorder in most patients. The patient and his partner have integral roles in the decision making process, since preferences regarding the importance of sexual activity, and the risks and benefits of treatment will vary greatly among individuals. References 1 : ImpotenceNIH Consensus Development Panel on Impotence. JAMA1993; 270: 83. Google Scholar 2 : Diagnostic and treatment strategies for erectile dysfunction: the ‘Process of Care’ model: University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. Int J Impot Res2000; 12: S119. Google Scholar 3 : Erectile dysfunction guideline update panel, chapter 1: the management of erectile dysfunction—an AUA update. J Urol2005; 174: 230. Link, Google Scholar 4 : Sexual dysfunction in the United States: prevalence and predictors. JAMA1999; 281: 537. Crossref, Medline, Google Scholar 5 : Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol1994; 151: 54. Link, Google Scholar 6 : Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol2001; 166: 569. Link, Google Scholar 7 : Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey. ’ Int J Impot Res2000; 12: 305. Google Scholar 8 : Hypertension is associated with severe erectile dysfunction. J Urol2000; 164: 1188. Link, Google Scholar 9 : Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int2001; 59: 2259. Google Scholar 10 : Erectile dysfunction. N Engl J Med2000; 342: 1802. Google Scholar 11 : Erectile dysfunction—the right to be treated. Int J Clin Pract1999; 53: 323. Google Scholar 12 : UK management guidelines for erectile dysfunction. BMJ2000; 321: 499. Google Scholar 13 : Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS2001; 15: 1019. Google Scholar 14 : Epidemiology of erectile dysfunction. Urol Clin North Am2001; 28: 209. Google Scholar 15 : Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA2003; 289: 56. Google Scholar 16 : Increased incidence of depressive symptoms in men with erectile dysfunction. Urology1998; 52: 848. Google Scholar 17 : Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am2001; 28: 269. Google Scholar 18 : Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?. Urology2000; 56: 302. Google Scholar 19 : Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med2000; 30: 328. Google Scholar 20 : Diagnostic evaluation of erectile dysfunction. Am Fam Physician2000; 61: 95. Google Scholar 21 : Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol1998; 160: 2216. Link, Google Scholar 22 : Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc1988; 36: 511. Google Scholar 23 : Smoking and erectile dysfunction: evidence based analysis. J Urol2001; 166: 1624. Link, Google Scholar 24 : Physician-patient dialogue and clinical evaluation of erectile dysfunction. Urol Clin North Am2001; 28: 249. Google Scholar 25 : Erectile dysfunction in cyclists. Is there any difference in penile blood flow during cycling in an upright versus a reclining position? Eur Urol2001; 39: 720. Google Scholar 26 : Sexual function in men with diabetes type 2: association with glycemic control. J Urol2000; 163: 788. Link, Google Scholar 27 : Hazards of bicycling: from handlebars to lightning. Semin Neurol2000; 20: 247. Google Scholar 28 : Pudendal nerve injury associated with avid bicycling. J Urol1999; 162: 2099. Link, Google Scholar 29 : Medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple’s problem—2003 update. Endocr Pract2003; 9: 77. Google Scholar 30 : Hormonal erectile dysfunction. Evaluation and management. Urol Clin North Am2001; 28: 279. Google Scholar 31 : Severe erectile dysfunction is a marker for hyperprolactinemia. Int J Impot Res2001; 13: 176. Google Scholar 32 : Psychological issues in diagnosis and treatment of erectile disorders. Urol Clin North Am1995; 22: 767. Google Scholar 33 : Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res1999; 11: 319. Google Scholar 34 : Evaluating the cardiovascular tolerance for sex. Am J Cardiol2000; 86: 51F. Google Scholar 35 : Onset and duration of action of sildenafil for the treatment of erectile dysfunction. Br J Clin Pharmacol2002; 53: 61S. Google Scholar 36 : Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol1998; 159: 2164. Link, Google Scholar 37 : Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res1996; 8: 47. Google Scholar 38 Cialis® package insert. Indianapolis: Lilly ICOS LLC2005. Google Scholar 39 Levitra® package insert. Research Triangle Park: GlaxoSmithKline2005. Google Scholar 40 Viagra® package insert. New York: Pfizer2005. Google Scholar 41 : Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology2002; 60: 28. Google Scholar 42 : Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl2001; 22: 793. Google Scholar 43 : Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res1998; 10: 69. Google Scholar 44 : Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl2002; 23: 763. Google Scholar 45 : Long-term efficacy of sildenafil and tachyphylaxis effect. J Urol2001; 166: 927. Link, Google Scholar 46 : Assessment of the efficacy and safety of Viagra® (sildenafil citrate) in men with erectile dysfunction during long-term treatment. Int J Impot Res2001; 13: 261. Google Scholar 47 : Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract2001; 55: 115. Google Scholar 48 : Clinical efficacy of sildenafil citrate and predictors of long-term response. J Urol2003; 170: 503. Link, Google Scholar 49 : Review of intraurethral suppositories and iontophoresis therapy for erectile dysfunction. Int J Impot Res2000; 12: S86. Google Scholar 50 : A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction. Urology2001; 57: 301. Google Scholar 51 : Male sexual circuitry. Sci Am2000; 283: 70. Google Scholar 52 : Second international consultation on sexual medicine: sexual dysfunctions in men and women. Paris: Health Publications2004. Google Scholar 53 : Recommendations of the First International Consultation on Erectile Dysfunction. Erectile Dysfunction. Plymouth, United Kingdom: Health Publication Ltd2000. Google Scholar 54 : Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo controlled study of 329 patients. Int J Clin Pract1998; 52: 375. Google Scholar 55 : Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol2002; 168: 1332. Link, Google Scholar 56 : The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res2001; 13: 192. Google Scholar Johns Hopkins University, Baltimore, Maryland© 2006 by American Urological AssociationFiguresReferencesRelatedDetailsCited byHirata H, Kawamoto K, Kikuno N, Kawakami T, Kawakami K, Saini S, Yamamura S and Dahiya R (2009) Restoring Erectile Function by Antioxidant Therapy in Diabetic RatsJournal of Urology, VOL. 182, NO. 5, (2518-2525), Online publication date: 1-Nov-2009.Marshall F, Montie J, Walsh P, Clayman R, Goldfarb D, Niederberger C, Seftel A and Canning D (2008) 2008 Best of the Rest in Urological SurveyJournal of Urology, VOL. 180, NO. 6, (2286-2296), Online publication date: 1-Dec-2008. Volume 175Issue 3SMarch 2006Page: S25-S31 Advertisement Copyright & Permissions© 2006 by American Urological AssociationKeywordspenile erectionphosphodiesterase VpenisimpotenceMetricsAuthor Information Arthur L. Burnett Financial interest and/or other relationship with Pfizer, Guilford Pharmaceuticals, Bayer/GlaxoSmithKline and Lilly/ICOS. More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W4249529992 created "2022-05-12" @default.
• W4249529992 creator A5037019692 @default.
• W4249529992 date "2006-03-01" @default.
• W4249529992 modified "2023-09-24" @default.
• W4249529992 title "Erectile Dysfunction" @default.
• W4249529992 cites W1219105037 @default.
• W4249529992 cites W1576999553 @default.
• W4249529992 cites W1966415714 @default.
• W4249529992 cites W1984494359 @default.
• W4249529992 cites W1986524770 @default.
• W4249529992 cites W1998245044 @default.
• W4249529992 cites W2002724710 @default.
• W4249529992 cites W2007606095 @default.
• W4249529992 cites W2009017711 @default.
• W4249529992 cites W2009639166 @default.
• W4249529992 cites W2013948844 @default.
• W4249529992 cites W2026641917 @default.
• W4249529992 cites W2027387814 @default.
• W4249529992 cites W2033319044 @default.
• W4249529992 cites W2049151984 @default.
• W4249529992 cites W2049472065 @default.
• W4249529992 cites W2052518051 @default.
• W4249529992 cites W2067814588 @default.
• W4249529992 cites W2067911532 @default.
• W4249529992 cites W2068913937 @default.
• W4249529992 cites W2075120690 @default.
• W4249529992 cites W2076357493 @default.
• W4249529992 cites W2077238418 @default.
• W4249529992 cites W2084976320 @default.
• W4249529992 cites W2088130312 @default.
• W4249529992 cites W2089271061 @default.
• W4249529992 cites W2091178888 @default.
• W4249529992 cites W2091806005 @default.
• W4249529992 cites W2092243607 @default.
• W4249529992 cites W2121939064 @default.
• W4249529992 cites W2145787505 @default.
• W4249529992 cites W2149500278 @default.
• W4249529992 cites W2158156040 @default.
• W4249529992 cites W2160170325 @default.
• W4249529992 cites W2297358297 @default.
• W4249529992 cites W2321389398 @default.
• W4249529992 cites W2325794787 @default.
• W4249529992 cites W2327417095 @default.
• W4249529992 cites W2404186313 @default.
• W4249529992 cites W2417164682 @default.
• W4249529992 cites W4230764065 @default.
• W4249529992 cites W4249523014 @default.
• W4249529992 cites W4365787279 @default.
• W4249529992 cites W4366572661 @default.
• W4249529992 cites W4367484259 @default.
• W4249529992 doi "https://doi.org/10.1016/s0022-5347(05)00309-5" @default.
• W4249529992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16458737" @default.
• W4249529992 hasPublicationYear "2006" @default.
• W4249529992 type Work @default.
• W4249529992 citedByCount "42" @default.
• W4249529992 countsByYear W42495299922012 @default.
• W4249529992 countsByYear W42495299922013 @default.
• W4249529992 countsByYear W42495299922015 @default.
• W4249529992 countsByYear W42495299922016 @default.
• W4249529992 countsByYear W42495299922018 @default.
• W4249529992 countsByYear W42495299922020 @default.
• W4249529992 countsByYear W42495299922021 @default.
• W4249529992 countsByYear W42495299922023 @default.
• W4249529992 crossrefType "journal-article" @default.
• W4249529992 hasAuthorship W4249529992A5037019692 @default.
• W4249529992 hasConcept C126322002 @default.
• W4249529992 hasConcept C126894567 @default.
• W4249529992 hasConcept C2779929075 @default.
• W4249529992 hasConcept C71924100 @default.
• W4249529992 hasConceptScore W4249529992C126322002 @default.
• W4249529992 hasConceptScore W4249529992C126894567 @default.
• W4249529992 hasConceptScore W4249529992C2779929075 @default.
• W4249529992 hasConceptScore W4249529992C71924100 @default.
• W4249529992 hasIssue "3S" @default.
• W4249529992 hasLocation W42495299921 @default.
• W4249529992 hasLocation W42495299922 @default.
• W4249529992 hasOpenAccess W4249529992 @default.
• W4249529992 hasPrimaryLocation W42495299921 @default.
• W4249529992 hasRelatedWork W1989989063 @default.
• W4249529992 hasRelatedWork W2003824313 @default.
• W4249529992 hasRelatedWork W2073008339 @default.
• W4249529992 hasRelatedWork W2165748411 @default.
• W4249529992 hasRelatedWork W2363006105 @default.
• W4249529992 hasRelatedWork W2392413698 @default.
• W4249529992 hasRelatedWork W2414261175 @default.
• W4249529992 hasRelatedWork W2418411438 @default.
• W4249529992 hasRelatedWork W2895304663 @default.
• W4249529992 hasRelatedWork W2118673085 @default.
• W4249529992 hasVolume "175" @default.
• W4249529992 isParatext "false" @default.
• W4249529992 isRetracted "false" @default.
• W4249529992 workType "article" @default.